As of 2026-09-17, the Relative Valuation of Vertex Pharmaceuticals Inc (VRTX) is 475.77 USD. This relative valuation is based on P/E multiples. With the latest stock price at 513.26 USD, the upside of Vertex Pharmaceuticals Inc based on Relative Valuation is -7.3%.
The range of the Relative Valuation is 416.37 - 636.63 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.8x - 36.7x | 30.6x |
| Forward P/E multiples | 24.6x - 29.2x | 24.8x |
| Fair Price | 416.37 - 636.63 | 475.77 |
| Upside | -18.9% - 24.0% | -7.3% |
| Date | P/E |
| 2026-09-16 | 29.57 |
| 2026-09-15 | 29.65 |
| 2026-09-14 | 29.93 |
| 2026-09-11 | 29.70 |
| 2026-09-10 | 29.65 |
| 2026-09-09 | 30.02 |
| 2026-09-08 | 30.47 |
| 2026-09-04 | 31.47 |
| 2026-09-03 | 32.15 |
| 2026-09-02 | 32.08 |
| 2026-09-01 | 31.55 |
| 2026-08-31 | 31.37 |
| 2026-08-28 | 31.21 |
| 2026-08-27 | 31.55 |
| 2026-08-26 | 31.53 |
| 2026-08-25 | 31.85 |
| 2026-08-24 | 31.55 |
| 2026-08-21 | 31.58 |
| 2026-08-20 | 31.13 |
| 2026-08-19 | 31.81 |
| 2026-08-18 | 30.43 |
| 2026-08-17 | 29.70 |
| 2026-08-14 | 29.14 |
| 2026-08-13 | 29.76 |
| 2026-08-12 | 30.29 |
| 2026-08-11 | 30.52 |
| 2026-08-10 | 30.19 |
| 2026-08-07 | 28.58 |
| 2026-08-06 | 27.89 |
| 2026-08-05 | 27.93 |
| 2026-08-04 | 27.58 |
| 2026-08-03 | 27.12 |
| 2026-07-31 | 27.49 |
| 2026-07-30 | 27.75 |
| 2026-07-29 | 27.85 |
| 2026-07-28 | 28.25 |
| 2026-07-27 | 27.60 |
| 2026-07-24 | 27.50 |
| 2026-07-23 | 27.26 |
| 2026-07-22 | 27.23 |
| 2026-07-21 | 27.77 |
| 2026-07-20 | 27.68 |
| 2026-07-17 | 27.98 |
| 2026-07-16 | 28.00 |
| 2026-07-15 | 27.49 |
| 2026-07-14 | 27.44 |
| 2026-07-13 | 27.67 |
| 2026-07-10 | 27.97 |
| 2026-07-09 | 28.61 |
| 2026-07-08 | 28.72 |